IP Library Granted Patent US 7,361,172
Granted Patent B2
US 7,361,172 · App. 10/455,486 · Granted Apr 22, 2008

Ultrasonic device and method for tissue coagulation

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,361,172
App. No.
10/455,486
Granted
Apr 22, 2008
Kind
B2
Abstract

An ultrasonic surgical device for the coagulation of animal tissue having an ultrasonic applicator and a movable jaw with a jaw surface adjacent the distal portion of the ultrasonic applicator for movement toward the applicator to a closed position at a predefined clearance of between about 0.075 to about 1.9 millimeters from the applicator. The device may also include a mechanical cutting element that can be extended into the clearance to cut the tissue and means to vary the predefined clearance without removing the applicator from the patient. Tissue coagulating and cutting can be maximized and performed separately and can be easily monitored by the surgeon.

Claims (45)

1. An ultrasonic surgical apparatus for the coagulation of animal tissue having a handle for manipulation by a surgeon, an ultrasonic transducer for generating ultrasonic vibration, and an ultrasonic applicator attached to the ultrasonic transducer and extending from the handle for delivery of ultrasonic vibrations to the animal tissue, wherein said apparatus further comprises:

a distal portion on the ultrasonic applicator having a generally round cross-section with a diameter between approximately 2 and 6 millimeters to provide a broad surface for coagulation and to avoid cutting of the animal tissue;

an elongated support member releasably attached to the surgical handle and extending to the distal portion of the ultrasonic applicator;

a movable jaw with a jaw surface attached to the elongated support member adjacent the distal portion of the ultrasonic applicator for movement toward said distal portion to a closed position at a predefined clearance of between about 0.075 to about 1.9 millimeters, from said distal portion, wherein the movable jaw is configured to grasp and hold the animal tissue during coagulation while allowing the animal tissue to flow and coagulate; and

a stop for establishing the predefined clearance.

2. The ultrasonic surgical apparatus of claim 1 wherein the predefined clearance is between about 0.075 and about 0.75 millimeters.

3. The ultrasonic surgical apparatus of claim 2 wherein the jaw surface in the closed position is generally parallel with the surface of the elongated support member.

4. The ultrasonic surgical device of claim 2 wherein the jaw surface is concave.

5. The ultrasonic surgical device of claim 2 wherein the jaw surface is convex.

6. The ulstrasonic surgical device of claim 2 wherein the jaw surface is flat.

7. The ultrasonic surgical device of claim 2 wherein the stop is located on the elongated support member.

8. The ultrasonic surgical device of claim 2 wherein the stop is located on the handle of the ultrasonic surgical device.

9. The ultrasonic surgical device of claim 2 wherein the predetermined clearance may be varied without requiring removal of the ultrasonic surgical device from the patient during a medical procedure.

10. An ultrasonic surgical apparatus for the treating of animal tissue having a handle for manipulation by a surgeon an ultrasonic transducer for generating ultrasonic vibration, and an ultrasonic applicator attached to the ultrasonic transducer and extending from the handle for delivery of ultrasonic vibrations to the animal tissue, wherein said apparatus further comprises:

a distal portion on the ultrasonic applicator having a generally round cross-section with a diameter between approximately 2 and 6 millimeters to provide a broad surface for coagulation and to avoid cutting of the animal tissue;

an elongated support member releasably attached to the surgical handle and extending to the distal portion of the ultrasonic applicator;

a movable jaw with a jaw surface attached to the elongated support member adjacent the distal portion of the ultrasonic applicator for movement toward said distal portion to a closed position at a predefined clearance of between about 0.075 to about 1.9 millimeters from said distal portion, wherein the movable jaw is configured to grasp and hold the animal tissue during coagulation while allowing the animal tissue to flow and coagulate as the animal tissue is heated by vibration of the ultrasonic applicator;

a stop for establishing the predefined clearance; and

a mechanical cutting device for movement parallel to the ultrasonic applicator to cut the animal tissue located between the ultrasonic applicator and the clamp.

11. The ultrasonic surgical apparatus of claim 10 wherein the predefined clearance is between about 0.075 and about 0.75 millimeters.

12. The ultrasonic surgical apparatus of claim 11 wherein the jaw surface in the closed position is generally parallel with the surface of the elongated support member.

13. The ultrasonic surgical device of claim 11 wherein the jaw surface is concave.

14. The ultrasonic surgical device of claim 11 wherein the jaw surface is convex.

15. The ultrasonic surgical device of claim 11 wherein the jaw surface is flat.

16. The ultrasonic surgical device of claim 11 wherein the stop is located on the elongated support member.

17. The ultrasonic surgical device of claim 11 wherein the stop is located on the handle of the ultrasonic surgical device.

18. The ultrasonic surgical device of claim 11 wherein the predetermined clearance may be varied without requiring removal of the ultrasonic surgical device from the patient during a medical procedure.

19. The ultrasonic surgical device of claim 11 wherein the mechanical cutting device is a blade.

20. A method for the surgical coagulation of animal tissue comprising:

locating a portion of the animal tissue between

an ultrasonic application having a generally round cross-section with a diameter between approximately 2 and 6 millimeters to provide a broad surface for coagulation and to avoid cutting of the animal tissue; and

a clamp located adjacent the ultrasonic tissue;

moving the clamp toward the ultrasonic applicator to a predefined clearance of between about 0.075 to about 1.9 millimeters from the ultrasonic applicator to grasp and hold the desired tissue during coagulation while providing a zone for tissue flow and coagulation, wherein the predetermined clearance is established by a stop; and

applying ultrasonic vibrations to the portion of the tissue via the ultrasonic applicator sufficient to cause coagulation of the tissue.

21. The method of claim 20 wherein the predefined clearance is about 0.075 and about 0.75 millimeters.

22. The method of claim 21 wherein the predetermined clearance may be varied without requiring removal of the ultrasonic surgical device from the patient during a medical procedure.

23. A method for-surgically treating animal tissue with minimal bleeding comprising:

locating the animal tissue between

an ultrasonic applicator having a generally round cross-section with a diameter between approximately 2 and 6 millimeters to provide a broad surface for coagulation and to avoid cutting of the animal tissue;

moving the clamp toward the ultrasonic applicator to a predefined clearance of between about 0.075 to about 1.9 millimeters from the ultrasonic applicator to grasp and hold the animal tissue during coagulation while providing a zone for tissue flow and coagulation as the animal tissue is heated by vibration of the ultrasonic applicator, wherein the predetermined clearance is established by a stop;

applying ultrasonic vibrations to the animal tissue via the ultrasonic applicator sufficient to cause coagulation of the animal tissue; and

cutting said tissue after it has been coagulated using a mechanical cutting device.

24. The method of claim 23 wherein the predefined clearance is between about 0.075 and about 0.75 millimeters.

25. The method of claim 24 wherein the predetermined clearance may be varied without requiring removal of the ultrasonic surgical device from the patient during a medical procedure.

26. The method of claim 24 wherein the mechanical cutting device is a blade.

Assignments (12)
RELEASE OF SECURITY INTEREST Recorded Nov 20, 2025
From: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
To: BAUSCH HEALTH AMERICAS, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH US, LLC; SOLTA MEDICAL, INC.; MEDICIS PHARMACEUTICAL CORPORATION; SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD.; SANTARUS, INC.; ORAPHARMA, INC.; PRECISION DERMATOLOGY, INC.
Reel/Frame 073637/0126 →
RELEASE OF SECURITY INTEREST Recorded Nov 20, 2025
From: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
To: BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH US, LLC; SOLTA MEDICAL, INC.; MEDICIS PHARMACEUTICAL CORPORATION; SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD.; SANTARUS, INC.; ORAPHARMA, INC.; PRECISION DERMATOLOGY, INC.; BAUSCH HEALTH AMERICAS, INC.
Reel/Frame 073654/0242 →
RELEASE OF SECURITY INTEREST Recorded Nov 20, 2025
From: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
To: BAUSCH HEALTH COMPANIES INC.; BAUSCH HEALTH, CANADA INC.; BAUSCH HEALTH IRELAND LIMITED; SOLTA MEDICAL IRELAND LIMITED
Reel/Frame 073654/0300 →
RELEASE OF SECURITY INTEREST Recorded Apr 8, 2025
From: BARCLAYS BANK PLC, AS COLLATERAL AGENT
To: SOLTA MEDICAL, INC.; PRECISION DERMATOLOGY, INC.; BAUSCH HEALTH IRELAND LIMITED (F/K/A/ VALEANT PHARMACEUTICALS IRELAND LIMITED); SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD; SANTARUS, INC.; MEDICIS PHARMACEUTICAL CORPORATION; HUMAX PHARMACEUTICAL S.A.; SOLTA MEDICAL IRELAND LIMITED; BAUSCH & LOMB MEXICO, S.A. DE C.V.; BAUSCH+LOMB OPS B.V.; BAUSCH HEALTH AMERICAS, INC.; BAUSCH HEALTH COMPANIES INC.; BAUSCH HEALTH HOLDCO LIMITED; BAUSCH HEALTH MAGYARORSZAG KFT (A/K/A BAUSCH HEALTH HUNGARY LLC); BAUSCH HEALTH POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA (F/K/A VALEANT PHARMA POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA); BAUSCH HEALTH US, LLC; BAUSCH HEALTH, CANADA INC. / SANTE BAUSCH, CANADA INC.; ICN POLFA RZESZOW SPOLKA AKCYJNA (A/K/A ICN POLFA RZESZOW S.A.); ORAPHARMA, INC.; PRZEDSIEBIORSTWO FARMACEUTYCZNE JELFA SPOLKA AKCYJNA (A/K/A PRZEDSIEBIORSTWO FARMACEUTYCZNE JELFA S.A.); SOLTA MEDICAL DUTCH HOLDINGS B.V.; V-BAC HOLDING CORP.; VRX HOLDCO LLC; 1261229 B.C. LTD.; 1530065 B.C. LTD.
Reel/Frame 070778/0199 →
INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Jun 9, 2023
From: BAUSCH HEALTH IRELAND LIMITED; SOLTA MEDICAL IRELAND LIMITED; MEDICIS PHARMACEUTICAL CORPORATION; ORAPHARMA, INC.; SALIX PHARMACEUTICALS, INC.; SOLTA MEDICAL, INC.; PRECISION DERMATOLOGY, INC.
To: BARCLAYS BANK PLC, AS COLLATERAL AGENT
Reel/Frame 063942/0001 →
SECURITY AGREEMENT (SECOND LIEN) Recorded Oct 5, 2022
From: BAUSCH HEALTH US, LLC; BAUSCH HEALTH AMERICAS, INC.; MEDICIS PHARMACEUTICAL CORPORATION; ORAPHARMA, INC.; PRECISION DERMATOLOGY, INC.; SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD.; SANTARUS, INC.; SOLTA MEDICAL, INC.
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 061606/0468 →
SECURITY AGREEMENT (FIRST LIEN) Recorded Oct 4, 2022
From: BAUSCH HEALTH US, LLC; BAUSCH HEALTH AMERICAS, INC.; MEDICIS PHARMACEUTICAL CORPORATION; ORAPHARMA, INC.; PRECISION DERMATOLOGY, INC.; SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD.; SANTARUS, INC.; SOLTA MEDICAL, INC.
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 061595/0066 →
SECURITY INTEREST Recorded Jun 13, 2022
From: BAUSCH HEALTH COMPANIES INC.; BAUSCH HEALTH, CANADA INC.; BAUSCH HEALTH IRELAND LIMITED; SOLTA MEDICAL IRELAND LIMITED
To: THE BANK OF NEW YORK MELLON
Reel/Frame 060346/0705 →
SECURITY AGREEMENT Recorded Feb 10, 2022
From: BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH US, LLC; SOLTA MEDICAL, INC.; MEDICIS PHARMACEUTICAL CORPORATION; SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD.; SANTARUS, INC.; ORAPHARMA, INC.; PRECISION DERMATOLOGY, INC.; BAUSCH HEALTH AMERICAS, INC.
To: THE BANK OF NEW YORK MELLON
Reel/Frame 059121/0001 →
SECURITY INTEREST Recorded Jun 8, 2021
From: BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH US, LLC; SOLTA MEDICAL, INC.; MEDICIS PHARMACEUTICAL CORPORATION; SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD.; SANTARUS, INC.; ORAPHARMA, INC.; PRECISION DERMATOLOGY, INC.; BAUSCH HEALTH AMERICAS, INC.
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 056811/0814 →
MERGER Recorded May 12, 2021
From: SOUND SURGICAL TECHNOLOGIES LLC
To: SOLTA MEDICAL, INC.
Reel/Frame 056214/0690 →
SECURITY INTEREST Recorded Mar 11, 2019
From: BAUSCH HEALTH AMERICAS, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH US, LLC; SOLTA MEDICAL, INC.; MEDICIS PHARMACEUTICAL CORPORATION; SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD.; SANTARUS, INC.; ORAPHARMA, INC.; PRECISION DERMATOLOGY, INC.
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 048556/0758 →